Identification of 4-acrylamido-N-(pyridazin-3-yl)benzamide as anti-COVID-19 compound: a DFTB, molecular docking, and molecular dynamics study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details